Literature DB >> 12614037

Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome.

Robert I Fox1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12614037     DOI: 10.1007/978-1-4615-0717-8_155

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  2 in total

Review 1.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

2.  Cevimeline hydrochloride improved cholinergic dysfunction in a patient with pure autonomic failure.

Authors:  Atsushi Ogata; Masayasu Kitano; Hajime Sano
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.